Showing 11-17 of 17 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Evaluating gene-modified hypo-immune PSCs for immune evasion in NHPs | Trustees of the University of Pennsylvania | Ji Lei | Cures | 01-June-2025 to 31-May-2027 | $749,999.08 |
| Engineering regulatory B cells to promote immune tolerance for islet cell replacement therapy: A novel opportunity to cure Type I diabetes | Trustees of the University of Pennsylvania | James Markmann | Cures | 01-October-2026 to 30-September-2029 | $598,995.17 |
| Insulin dose and vascular complications in T1D: its role beyond insulin resistance and glycemia | University of Pittsburgh | Rachel Miller | Improving Lives | 01-July-2026 to 30-June-2029 | $749,947.12 |
| New approach for tolerance induction after allogeneic islets transplantation | University of Pittsburgh | Eric Lagasse | Cures | 01-September-2026 to 31-August-2027 | $249,994.05 |
| Dock2-mediated T cell migration as a targetable shared mechanism in autoimmunity | University of Pittsburgh | Alok Joglekar | Cures | 01-September-2025 to 28-February-2027 | $149,999.05 |
| Engineered Regulatory T cells for Suppression of Type 1 Diabetes | University of Pittsburgh | Alok Joglekar | Cures | 01-August-2026 to 31-July-2028 | $187,584.10 |
| Accelerating the Identification and Mitigation of Insulin Pump Risks using Artificial Intelligence | Veterans Health Foundation | Ronald Codario | Improving Lives | 01-August-2026 to 31-July-2027 | $189,038.48 |